Skip to content

Effect of Spinal or Sevoflurane Anesthesia on Neutrophil Activation During Knee Surgery With Pneumatic Tourniquet

Effect of Spinal or Sevoflurane Anesthesia on Neutrophil Activation After Tourniquet Induced Ischemia-reperfusion in Knee Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03470363
Enrollment
40
Registered
2018-03-19
Start date
2016-01-01
Completion date
2018-03-01
Last updated
2020-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Surgery With Tourniquet

Keywords

total knee arthroplasty, tourniquet, sevoflurane, spinal anesthesia, myeloperoxidase, elastase, neutrophil

Brief summary

Aim of study : Assessement of neutrophil activation during ischemia reperfusion associated with tourniquet use for total knee arthroplasty. This activation was compared in a group of patient scheduled for spinal anesthesia and for sevoflurane anesthesia

Detailed description

Aim of study : Assessement of neutrophil activation during ischemia reperfusion associated with tourniquet use for total knee arthroplasty. This activation was compared in a group of patient scheduled for spinal anesthesia and for sevoflurane anesthesia This activation was assessed by plasma myeloperoxidase and elastase measurements in four consecutive blood samples during and after surgery (before surgical incision and 1, 3, 24 hours following tourniquet release.

Interventions

DRUGSevoflurane Volatile Liquid
DRUGBupivacaine / SUFentanil

Sponsors

University of Liege
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Total knee arthroplasty under spinal or sevoflurane anesthesia

Exclusion criteria

* American Society of Anesthesiologists class 3 and 4 * vascular disease of the lower limbs * cardiac or respiratory disease * immune disorder

Design outcomes

Primary

MeasureTime frameDescription
Changes in plasmatic concentration of myeloperoxidase and elastaseBefore surgical incision and one hour after tourniquet releaseBiological measurement of changes in plasmatic concentration of myeloperoxidase and elastase from preoperative values to one hour after tourniquet release.

Secondary

MeasureTime frameDescription
Changes in plasmatic concentration of endothelial biomarkersBefore surgical incision and one hour after tourniquet releaseBiological measurement of changes in plasmatic concentration of syndecan-1, soluble thrombomodulin, soluble E-selectin and VEGF from preoperative values to one hour after tourniquet release.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026